Global food manufacturer Danone has released its financial results for Q1 2025, indicating a “strong start” to the year.
The company reported sales of €6,844 million, up +4.3% on a like-for-like (LFL) basis, with broad-based growth demonstrating “business resilience”.
Danone found that its performance in China, North Asia and Oceania was “very strong” across all categories. Its North America division saw “solid growth”, led by continued momentum in High Protein.
In Q1 2025, Europe LFL sales were up +2.0%, driven by volume/mix at +1.9%, while price was flat. The zone improved its growth momentum sequentially while achieving positive volume/mix for the sixth consecutive quarter. It was led by further progress in EDP, supported by functional products, and particularly the YoPro, Alpro, and Actimel brands.
Danone CEO Antoine de Saint-Affrique commented: “With a +4.3% like-for-like sales growth in Q1, we have delivered a strong start to the year, across all categories, demonstrating the strength of our execution and the relevance of our health-focused portfolio.
“In the current uncertain environment, our science-based innovations, our consumer and patient-centric approach, and our increasingly diversified channel footprint further contribute to the resilience of our business. We are confident that 2025 will be another year where we deliver on our value creation model, aligned with our mid-term ambitions.”
